Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

OostNL

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 57
Average round size
info
The average size of a deal this fund participated in
$6M
Portfolio companies 47
Rounds per year 2.71
Lead investments 7
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.18
Key employees 25

Areas of investment

  • Health Care
  • Medical Device
  • Biotechnology
  • Medical
  • Information Technology
Summary

The venture was found in Europe in The Netherlands.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - The Netherlands. We can highlight the next thriving fund investment areas, such as Energy, Medical. Among the most popular portfolio startups of the fund, we may highlight Mellon Medical, Mimetas, Xenikos.

The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2017.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the OostNL, startups are often financed by Zeeuws Investerings Fonds, Thuja Capital, PMV. The meaningful sponsors for the fund in investment in the same round are Thuja Capital, Sanquin Blood Supply Foundation, Next-Gen Ventures. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs, RA Capital Management, Medicxi Ventures.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of OostNL:
Typical Co-investors
OostNL is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after OostNL:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerate Ventures Springville, United States, Utah
FacePaint New York, New York, United States
HNA Group China, Haikou, Hainan
Human Longevity and Performance Impact Venture Fund -
Investis Group Switzerland, Zürich, Zurich
Jishu Ventures China, Guangdong, Shenzhen
Kyros Ventures -
Metatron Global Czech Republic, Prague, Prague
Penja Strategy -
Plantree Partners -
Properties Chicago, Illinois, United States
Redstone Berlin, Berlin, Germany
SIP Joinne MingYuan Venture Capital China, Jiangsu, Suzhou
Sumitomo Corporation Chiyoda, Japan
Thayer Street Partners New York, New York, United States
Vechain Central, Central Region, Singapore
VIVA Investment Partners Switzerland, Zollikon, Zurich
Wildcat Capital Management Fort Worth, Texas, United States
Yuan Zhen Capital Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

NoPalm-Ingredients

$5M24 Jul 2024 -

Hexwise

Energy Efficiency
Renewable Energy
11 Apr 2024 The Netherlands, Flevoland, Netherlands

Time-Travelling Milkman

$1M20 Feb 2024 Wageningen, Gelderland, The Netherlands

Brilliance

Augmented Reality
Laser
Manufacturing
$2M29 Nov 2023 Enschede, Overijssel, The Netherlands

SuperLight Photonics

Information Technology
Laser
14 Sep 2023 Enschede, Overijssel, The Netherlands

Tagworks Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$65M22 Jun 2023 Nijmegen, Gelderland, The Netherlands

Delta Diagnostics

Management Consulting
$6M09 May 2023 Bengaluru, Karnataka, India

FUMI Ingredients

Biotechnology
Food Processing
$9M02 May 2023 The Netherlands, Gelderland, Netherlands

PEF Technologies

Food and Beverage
Food Processing
$1M31 Mar 2023 Arnhem, Gelderland, The Netherlands

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent OostNL?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 57
Average round size 6M
Rounds per year 2.71
Peak activity year 2022
Lead investments 7
Follow on index 0.18
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

NoPalm-Ingredients

$5M24 Jul 2024 -

Hexwise

Energy Efficiency
Renewable Energy
11 Apr 2024 The Netherlands, Flevoland, Netherlands

Time-Travelling Milkman

$1M20 Feb 2024 Wageningen, Gelderland, The Netherlands

Brilliance

Augmented Reality
Laser
Manufacturing
$2M29 Nov 2023 Enschede, Overijssel, The Netherlands

SuperLight Photonics

Information Technology
Laser
14 Sep 2023 Enschede, Overijssel, The Netherlands

Tagworks Pharmaceuticals

Biotechnology
Health Care
Medical
Pharmaceutical
$65M22 Jun 2023 Nijmegen, Gelderland, The Netherlands

Delta Diagnostics

Management Consulting
$6M09 May 2023 Bengaluru, Karnataka, India

FUMI Ingredients

Biotechnology
Food Processing
$9M02 May 2023 The Netherlands, Gelderland, Netherlands

PEF Technologies

Food and Beverage
Food Processing
$1M31 Mar 2023 Arnhem, Gelderland, The Netherlands
Crunchbase icon

Content report

The following text will be sent to our editors: